The immune profile of ACO diverges from COPD by incorporating both innate and adaptive immune responses, with a notable emphasis on T cell activation and interferon-gamma pathways, unlike COPD, which is largely driven by innate mechanisms such as neutrophil activation and NF-κB signalling. The gene discussed is IFNG; the disease is chronic obstructive pulmonary disease.